A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales
Article in PharmacoEconomics - Open (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in PharmacoEconomics - Open (March 2024)
Article in Expert Review of Neurotherapeutics (March 2024)
Article in ACS Medicinal Chemistry Letters (January 2024)